Evidence map›Paper›PMID 41273562›Full record

SynthesisAdvances in experimental medicine and biology2026

Recent Advances in Psychological Interventions Targeting Cognitive Dysfunction in Adults with Major Depressive Disorder: A Systematic Review.

Maria-Alexandra Katsifi, Elena Critselis, Xanthi Tigani, Dimitrios Vlachakis, Christina Kanaka-Gantenbein, Flora Bacopoulou

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria-Alexandra KatsifiPostgraduate Course on the Science of Stress and Health Promotion, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Elena CritselisPostgraduate Course on the Science of Stress and Health Promotion, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Xanthi TiganiPostgraduate Course on the Science of Stress and Health Promotion, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios VlachakisLaboratory of Genetics, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece.
Christina Kanaka-GantenbeinPostgraduate Course on the Science of Stress and Health Promotion, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.
Flora BacopoulouPostgraduate Course on the Science of Stress and Health Promotion, Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece. fbacopoulou@med.uoa.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Major depressive disorder (MDD) is a frequently occurring and impairing mental health condition marked by cognitive deficits in several areas, such as attention, executive functions, information processing speed, and memory. It is noteworthy that while affective symptoms of MDD tend to subside when the depressive episode is resolved, cognitive impairment frequently persists and increases the risk of relapse. The present study systematically collected and assessed evidence from the past 10 years of randomized controlled clinical trials targeting cognitive deficiencies in adults with MDD through the implementation of psychological interventions, specifically cognitive remediation therapy or cognitive behavioral therapy. A comprehensive search was conducted in the PubMed and Web of Science databases from January 1, 2013, to July 31, 2023. A total of 520 studies were initially identified, and six of them met the inclusion criteria, in accordance with the PRISMA guidelines. Participants in the intervention groups were 187, and 125 in the control groups. Most studies showed significant improvements in attention and self-assessed everyday performance. Findings pertaining to executive function and verbal learning and memory varied, with some studies conveying significant improvements in those domains post-intervention, and others failing to demonstrate any statistically significant effects. The results showcased the need to conduct larger, meticulously designed, double-blind randomized controlled trials with standardized measurement tools to more accurately evaluate the efficacy of those non-pharmaceutical interventions. Future research is warranted to investigate deficits in verbal memory, verbal learning, and executive function, since these domains seem to be the most resistant to change.

Indexed as

Cognitive Behavioral TherapyCognitive DysfunctionMajor Depressive DisorderAdultCognitionExecutive FunctionHumansRandomized Controlled Trials as TopicTreatment OutcomeBehavioralCBTCognitiveCognitive behavioral therapyCognitive remediation therapyCRTDepressionInterventionMajor depressive disorderMental healthPsychological

Identifiers

PMID41273562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.